Status:
TERMINATED
Timing for Removal of Chest Tubes in Adult Cardiac Surgery
Lead Sponsor:
Aarhus University Hospital Skejby
Conditions:
Heart Surgery
Chest Tube
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Rationale: Evidence regarding the timing of chest tube removal after cardiac surgery is sparse. The timing of chest tubes removal constitutes a balancing act between risk of retained blood syndrome, ...
Eligibility Criteria
Inclusion
- All consecutive patients undergoing elective open heart surgery in full or lower hemisternotomy with or without cardiopulmonary bypass including coronary artery bypass grafting, valve surgery, simple aortic surgery or combinations.
Exclusion
- Cardiac procedures deemed not eligible to chest tube removal on the day of surgery due to increased bleeding risk due to:
- Procedures in hypothermic circulatory arrest
- Previous cardiac surgery
- Procedures performed through upper hemisternotomy
- Emergent treatment required (\< 24 hours)
- Non-aspirin antiplatelet drugs stopped \< 5 days preoperatively (Clopidogrel, Prasugrel, Ticagrelor, Ticlopidine)
- Current use of vitamin K antagonists or new oral non-vitamin K anticoagulants
- Platelet count \> 450 or \<100 x 109/l prior to surgery
Key Trial Info
Start Date :
September 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 31 2021
Estimated Enrollment :
515 Patients enrolled
Trial Details
Trial ID
NCT04487262
Start Date
September 1 2020
End Date
October 31 2021
Last Update
August 8 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dep. of Cardiothoracic Surgery, Aarhus University Hospital
Aarhus, Denmark, 8200